Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Astrazeneca Plc ADR (AZN)

Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 271,666,848
  • Shares Outstanding, K 3,100,512
  • Annual Sales, $ 45,811 M
  • Annual Income, $ 5,955 M
  • 60-Month Beta 0.45
  • Price/Sales 5.91
  • Price/Cash Flow 16.18
  • Price/Book 6.84
Trade AZN with:

Options Overview Details

View History
  • Implied Volatility 18.15% ( -0.42%)
  • Historical Volatility 16.62%
  • IV Percentile 2%
  • IV Rank 15.42%
  • IV High 31.19% on 10/16/23
  • IV Low 15.77% on 05/28/24
  • Put/Call Vol Ratio 1.26
  • Today's Volume 5,577
  • Volume Avg (30-Day) 7,084
  • Put/Call OI Ratio 1.20
  • Today's Open Interest 117,331
  • Open Int (30-Day) 103,121

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 1.08
  • Number of Estimates 6
  • High Estimate 1.24
  • Low Estimate 0.98
  • Prior Year 0.87
  • Growth Rate Est. (year over year) +24.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
78.22 +12.02%
on 08/06/24
87.68 -0.06%
on 08/30/24
+9.72 (+12.48%)
since 07/30/24
3-Month
76.30 +14.84%
on 07/09/24
87.68 -0.06%
on 08/30/24
+10.85 (+14.13%)
since 05/30/24
52-Week
60.47 +44.90%
on 02/12/24
87.68 -0.06%
on 08/30/24
+18.48 (+26.73%)
since 08/29/23

Most Recent Stories

More News
As Radiotherapy Redefines Cancer Care, Here's the Stock to Buy Near 52-Week Highs

A new generation of radiotherapies are redefining cancer care, offering the potential for a more powerful treatment with fewer side effects. It could become a mainstream therapy for the big "traditional"...

LLY : 960.02 (+2.11%)
AZN : 87.62 (+0.37%)
BMY : 49.95 (+0.46%)
NVS : 120.89 (+0.39%)
PFE : 29.01 (+1.01%)
Here's What AstraZeneca's CEO Has to Say About the Weight Loss Drugs Market

The winners of today might not compete in the lucrative new segment of tomorrow.

LLY : 960.02 (+2.11%)
AZN : 87.62 (+0.37%)
3 Surprisingly Underrated Stocks to Buy Right Now

These stocks arguably deserve more respect from investors.

XLV : 157.20 (+0.69%)
AZN : 87.62 (+0.37%)
PFE : 29.01 (+1.01%)
VTRS : 12.08 (+1.60%)
Why AstraZeneca Stock Is Sliding Today

The British drugmaker's Q2 results were good, but seemingly not good enough for many investors.

AZN : 87.62 (+0.37%)
AstraZeneca Plc (AZN) Q2 2024 Earnings Call Transcript

AZN earnings call for the period ending June 30, 2024.

AZN : 87.62 (+0.37%)
AbbVie Could Soar 24%, According to a Wall Street Analyst. Is the High-Yield Dividend Stock a Buy Now?

The big pharma company's top drug is losing ground, but its dividend keeps rising.

CVS : 57.24 (+0.47%)
UNH : 590.20 (-0.23%)
ABT : 113.27 (+0.45%)
CI : 361.81 (+0.21%)
AZN : 87.62 (+0.37%)
BGNE : 191.78 (-3.39%)
RVNC : 6.57 (unch)
ABBV : 196.31 (+0.58%)
1 'Strong Buy' Biotech Stock With 132% Upside Potential

Analysts expect this small-cap biotech stock to more than double in value as it integrates AI into its drug development process.

ABSI : 4.40 (+2.33%)
MS : 103.61 (+0.98%)
AZN : 87.62 (+0.37%)
ALM.E.DX : 8.855 (+1.20%)
3 No-Brainer Stocks to Buy for Under $100 Right Now

You won't need much money to start investing in these great stocks.

AZN : 87.62 (+0.37%)
BMY : 49.95 (+0.46%)
PFE : 29.01 (+1.01%)
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GOVX),(NYSE:GSK),(NASDAQ:AZN),(NYSE:MRK) EQNX::TICKER_END

ONCY : 0.9590 (+0.66%)
ONC.TO : 1.28 (unch)
GOVX : 4.63 (-6.46%)
GSK : 43.91 (+0.39%)
AZN : 87.62 (+0.37%)
MRK : 118.45 (+0.84%)
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth

ONCY : 0.9590 (+0.66%)
ONC.TO : 1.28 (unch)
GOVX : 4.63 (-6.46%)
GSK : 43.91 (+0.39%)
AZN : 87.62 (+0.37%)
MRK : 118.45 (+0.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

AstraZeneca plc, is one of the largest biopharmaceutical companies in the world. AstraZeneca's business can be broken down into separate lines based on therapeutic classes. These include cardiovascular, respiratory, immunology, oncology, rare diseases and other.In July 2021 AstraZeneca closed the acquisition...

See More

Key Turning Points

3rd Resistance Point 88.70
2nd Resistance Point 88.19
1st Resistance Point 87.90
Last Price 87.62
1st Support Level 87.11
2nd Support Level 86.60
3rd Support Level 86.31

See More

52-Week High 87.68
Last Price 87.62
Fibonacci 61.8% 77.28
Fibonacci 50% 74.07
Fibonacci 38.2% 70.86
52-Week Low 60.47

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar